Complete response to sunitinib in a patient with relapsed irresectable renal cell carcinoma

被引：4
|
作者：
Angeles Vaz, Maria [1 ]
Pachon, Vanessa [1 ]
Grande, Enrique [1 ]
Ferreiro, Reyes [1 ]
Carrato, Alfredo [1 ]
机构：
[1] Ramon y Cajal Univ Hosp, Dept Med Oncol, Madrid, Spain
来源：
ANTI-CANCER DRUGS | 2011年 / 22卷 / 08期
关键词：
complete response; renal cell carcinoma; sunitinib; tyrosine kinase inhibitors; INTERFERON-ALPHA; SURVIVAL; THERAPY; CANCER; MANAGEMENT; RESECTION;
D O I：
10.1097/CAD.0b013e3283437ff9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We report a case with a complete pathology-proven remission after sunitinib treatment of a relapsed irresectable clear cell renal carcinoma. A significant objective response was observed with tumor size reduction during treatment. After surgery, on pathologic examination it was concluded that the patient exhibited a complete response; activity and the feasibility and safety of subsequent surgical resection were assessed. Otherwise after discontinuing sunitinib, the patient had a relapse on the same location; sunitinib has been resumed and was again found to be effective. Anti-Cancer Drugs 22:817-821 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码：817 / 821
页数：5
相关论文
共 50 条
  • [1] Complete Response After Sequential Sunitinib-Sorafenib Treatment in a Patient With Renal Cell Carcinoma: A Case Report
    Verzoni, Elena
    Lanocita, Rodolfo
    Procopio, Giuseppe
    CLINICAL GENITOURINARY CANCER, 2012, 10 (02) : 130 - 133
  • [2] Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma: the fine balance between toxicity and efficacy
    Massari, Francesco
    Ciccarese, Chiara
    Bimbatti, Davide
    Fantinel, Emanuela
    Modena, Alessandra
    Simbolo, Michele
    Brunelli, Matteo
    Artibani, Walter
    Martignoni, Guido
    Scarpa, Aldo
    Tortora, Giampaolo
    ANTI-CANCER DRUGS, 2015, 26 (04) : 469 - 473
  • [3] An Unusual Metastatic Renal Cell Carcinoma with Maintained Complete Response to Sunitinib Treatment
    Chara, Luis
    Rodriguez, Beatriz
    Holgado, Esther
    Ramirez, Natalia
    Fernandez-Ranada, Isabel
    Mohedano, Nicolas
    Arcediano, Alberto
    Garcia, Ines
    Cassinello, Javier
    CASE REPORTS IN ONCOLOGY, 2011, 4 (03): : 583 - 586
  • [4] Multifocal Brain Metastases in Clear Cell Renal Cell Carcinoma with Complete Response to Sunitinib
    Zeng, Hao
    Li, Xiang
    Yao, Jin
    Zhu, Yuchun
    Liu, Jiyan
    Yang, Yuru
    Qiang, Wei
    UROLOGIA INTERNATIONALIS, 2009, 83 (04) : 482 - 485
  • [5] Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib
    de Velasco, Guillermo
    Alonso-Gordoa, Teresa
    Rodriguez-Vida, Alejo
    Anguera, Georgia
    Campayo, Marc
    Pinto, Alvaro
    Ortega, Esther Martinez
    Gallardo, Enrique
    Nunez, Natalia Fernandez
    Garcia-Carbonero, Iciar
    Reig, Oscar
    Mendez-Vidal, Maria Jose
    Fernandez-Calvo, Ovidio
    Cassinello, Natalia Vidal
    Torregrosa, Dolores
    Lopez-Martin, Ana
    Rosero, Adriana
    Valiente, Patricia G.
    de Espana, Carmen Garcias
    Climent, Miguel A.
    Santasusana, Montserrat Domenech
    Sanchez, Angel Rodriguez
    Gonzalez, Isabel Chirivella
    Afonso, Ruth
    del Muro, Xavier Garcia
    Casinello, Javier
    Fernandez-Parra, Eva M.
    Sanchez, Lourdes Garcia
    Afonso, Javier
    Polo, Susana Hernando
    Asensio, Ursula
    CLINICAL GENITOURINARY CANCER, 2023, 21 (03) : e166 - e174
  • [6] Alternate sunitinib schedules in patients with metastatic renal cell carcinoma
    Kalra, S.
    Rini, B. I.
    Jonasch, E.
    ANNALS OF ONCOLOGY, 2015, 26 (07) : 1300 - 1304
  • [7] Complete Pathological Response after Sequential Therapy with Sunitinib and Radiotherapy for Metastatic Clear Cell Renal Carcinoma
    Venton, Geoffroy
    Ducournau, Aurelie
    Gross, Emmanuel
    Lechevaller, Eric
    Rochwerger, Alexandre
    Curvale, Georges
    Zink, Jean-Vincent
    Salas, Sebastien
    Deville, Jean-Laurent
    ANTICANCER RESEARCH, 2012, 32 (02) : 701 - 705
  • [8] Complete remission of metastatic renal cell carcinoma to the bone with sunitinib
    Yoshimura, Akihiro
    Nakata, Wataru
    Yamamichi, Gaku
    Tsujimura, Go
    Tsujimoto, Yuichi
    Nin, Mikio
    Tsujihata, Masao
    UROLOGY CASE REPORTS, 2020, 32
  • [9] Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma
    Mizuno, Ryuichi
    Kimura, Go
    Fukasawa, Satoshi
    Ueda, Takeshi
    Kondo, Tsunenori
    Hara, Hidehiko
    Shoji, Sunao
    Kanao, Kent
    Nakazawa, Hayakazu
    Tanabe, Kazunari
    Horie, Shigeo
    Oya, Mototsugu
    CANCER SCIENCE, 2017, 108 (09): : 1858 - 1863
  • [10] Sorafenib and sunitinib for elderly patients with renal cell carcinoma
    Miled, Olfa Derbel
    Dionne, Christine
    Terret, Catherine
    Segura-Ferlay, Celine
    Flechon, Aude
    Neidhart, Eve-Marie
    Negrier, Sylvie
    Droz, Jean-Pierre
    JOURNAL OF GERIATRIC ONCOLOGY, 2013, 4 (03) : 255 - 261
12345